Introduction: Co-occurring disorders (CODs) describe a Substance Use Disorder (SUD) accompanied by a comorbid psychiatric disorder. Attention-Deficit/Hyperactivity Disorder (ADHD) and mood disorders are common CODs with high prevalence rates in SUD populations. It is proposed that literature on a tri-condition presentation of ADHD, mood disorder and SUD is limited. Areas covered: A literature search was conducted using a keyword search on EBSCOhost. Initially 2 799 records were identified, however, only two articles included all three conditions occurring concurrently in individuals. CODs constitute a major concern due to their overarching burden on society as a whole. Diagnosis and treatment of such patients is challenging. There is evidence that dysfunction of dopamine in the brain reward circuitry impacts the development or symptomology of all three disorders. Disparity exists regarding whether ADHD or mood disorders are greater modifiers for increased SUD severity. However, it has been reported that poor functional capacity may have a greater influence than comorbidities on SUD development. Expert commentary: Challenges exist which confound the clear distinction of CODs, however, with greater emergence of adult ADHD its screening in SUD populations should become standard practice to establish data on multi-condition presentations with the ultimate goal of improving clinical outcomes.
22 May 2019 in South African Journal of Psychiatry
The South African Journal of Psychiatry publishes topical content in psychiatry for clinical practice and academic pursuits, including work in the subspecialty areas of psychiatry.
31 March 2014 in Journal of Child & Adolescent Mental Health
Attention deficit hyperactivity disorder (ADHD) is a prevalent disorder affecting people in all age groups. Pharmacological treatment with psychostimulants, specifically methylphenidate, is first line management. The ideal dosing regimen of methylphenidate is debatable with daily use being considered harmful by many. However, it is unknown if sporadic drug withdrawal is beneficial to management. The primary aim was to investigate drug holiday utilisation incidence.The study comprised a drug utilisation review (DUR) and questionnaire-based survey. The DUR was conducted using a corporate retail pharmacy group database. Methylphenidate prescriptions were evaluated to determine possible drug holiday use through different analyses of dispensing patterns. The survey included several questions relating to drug holiday use.Drug holiday use was identified in both study populations. Weekends and school holidays were identified as common periods for drug holiday observation. Of the participants that provided reasons for drug holiday utilisation, half indicated that methylphenidate was only necessary for school activities. DUR results indicated that drug holidays appeared to be more commonly observed during March and December.Reasons for drug holiday utilisation were variable. This study recommends that these drug free periods are only observed if shown to be beneficial to the patient.
Background: The brain reward circuitry is thought to underlie the co-occurrence of attention-deficit/hyperactivity disorder (ADHD) and substance use disorder (SUD) and to possibly impact mood disorders. This study aimed to establish if any difference existed in the severity of depression symptomology between SUD comorbidity with and without ADHD. Methods: A multi-centre, cross-sectional comparison study design drew study participants from substance use treatment facilities within South Africa. The participants were screened for ADHD and depression, with the selective application of a confirmatory ADHD diagnostic interview. The participants were diagnostically grouped according (SUD + ADHD, SUD − ADHD) to an application of a 2 x 2 x 3 ANOVA model. Results: A significant main effect of ADHD diagnosis and gender on depressive symptoms was identified. Post hoc analysis revealed that only male ADHD subjects had significantly higher scores on the Beck scale than non-ADHD males. Conclusions: Co-occurring disorder (COD) prevalence rates were higher than most other South African studies. The aggravation of ADHD on mood disorder symptom severity is consistent with the existing literature; however, further investigation is warranted to determine if the interaction of gender remains only significant for men with a lager sample size. The identified COD prevalence rate may contrast with other South Africa studies, emphasising the need for comprehensive psychiatric comorbidity screening in SUD treatment settings.
Background: The brain reward circuitry is contemplated to underlie co-occurrence of At-tention-Deficit/Hyperactivity Disorder (ADHD) and Substance Use Disorder (SUD) and to possibly impact mood disorders. This study aimed to establish if any difference existed in the severity of depression symptomology between SUD comorbid with and without ADHD. Methods: A multi-centre, cross-sectional comparison study design drew study participants from substance use treatment facilities within South Africa. Participants were screened for ADHD and depression, with selective application of a confirmatory ADHD diagnostic interview. Participants were diagnostically grouped according (SUD + ADHD, SUD – ADHD) with application of a 2x2x3 ANOVA model. Results: A significant main effect of ADHD diagnosis and gender on depressive symptoms was identified. Post-hoc analysis revealed only male ADHD subjects had significantly higher scores on the Beck Scale than non-ADHD males. Conclusions: Co-occurring disorder (COD) prevalence rates were higher than most other South African studies. Aggravation of ADHD on mood dis-order symptom severity is consistent with existing literature, however further investiga-tion is warranted to determine if the interaction of gender remains only significant for men with a bigger sample size. The identified COD prevalence rate contrasts with other South Africa studies, emphasising the need for comprehensive psychiatric co-morbidity screen-ing in SUD treatment settings.